SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $280,503 | -9.0% | 2,314 | +3.4% | 0.00% | 0.0% |
Q2 2023 | $308,325 | 0.0% | 2,237 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $308,325 | +6.2% | 2,237 | -0.2% | 0.00% | 0.0% |
Q4 2022 | $290,388 | +19.5% | 2,241 | +1.5% | 0.00% | 0.0% |
Q3 2022 | $243,000 | -29.2% | 2,208 | +9.2% | 0.00% | 0.0% |
Q4 2020 | $343,000 | +15.5% | 2,022 | -4.9% | 0.00% | 0.0% |
Q3 2020 | $297,000 | -12.6% | 2,126 | -0.1% | 0.00% | 0.0% |
Q2 2020 | $340,000 | +25.0% | 2,128 | +0.9% | 0.00% | +100.0% |
Q1 2020 | $272,000 | 0.0% | 2,109 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $272,000 | +72.2% | 2,109 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $158,000 | -50.6% | 2,109 | -0.2% | 0.00% | 0.0% |
Q2 2019 | $320,000 | +27.5% | 2,113 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $251,000 | +14.6% | 2,113 | +5.0% | 0.00% | 0.0% |
Q4 2018 | $219,000 | -32.2% | 2,013 | +0.6% | 0.00% | 0.0% |
Q3 2018 | $323,000 | +22.3% | 2,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $264,000 | +107.9% | 2,000 | -13.0% | 0.00% | 0.0% |
Q1 2018 | $127,000 | 0.0% | 2,300 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $127,000 | +41.1% | 2,300 | +15.0% | 0.00% | – |
Q3 2017 | $90,000 | +52.5% | 2,000 | 0.0% | 0.00% | – |
Q2 2017 | $59,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2017 | $59,000 | +9.3% | 2,000 | 0.0% | 0.00% | – |
Q4 2016 | $54,000 | -56.5% | 2,000 | -1.9% | 0.00% | -100.0% |
Q3 2016 | $124,000 | +226.3% | 2,038 | +1.9% | 0.00% | – |
Q2 2016 | $38,000 | -2.6% | 2,000 | 0.0% | 0.00% | – |
Q1 2016 | $39,000 | -49.4% | 2,000 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $77,000 | +20.3% | 2,000 | 0.0% | 0.00% | – |
Q3 2015 | $64,000 | +6.7% | 2,000 | 0.0% | 0.00% | – |
Q2 2015 | $60,000 | -34.8% | 2,000 | -71.4% | 0.00% | -100.0% |
Q1 2015 | $92,000 | -8.9% | 7,000 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $101,000 | -17.2% | 7,000 | +20.7% | 0.00% | 0.0% |
Q3 2014 | $122,000 | -29.1% | 5,800 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $172,000 | +23.7% | 5,800 | 0.0% | 0.00% | +100.0% |
Q1 2014 | $139,000 | +17.8% | 5,800 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $118,000 | -52.2% | 5,800 | +10.8% | 0.00% | -66.7% |
Q3 2013 | $247,000 | +30.0% | 5,235 | +4.7% | 0.00% | +50.0% |
Q2 2013 | $190,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |